NewsSource: EClinCloud

[Invitation] EClinCloud Invites You to the Linyanren 2022 Annual Conference and Clinical Trial Management and Technology Innovation Forum

2 min readEClinCloud Editorial Team
Article image

Source: EClinCloud. Author: EClinCloud.






"

In recent years, with the arrival of a new era of technological revolution in digitalization and artificial intelligence, the deepening development of the pharmaceutical innovation industry and drug review and approval system reforms, and the ongoing impact of the COVID-19 pandemic, clinical trial management and clinical trial technologies in China face new opportunities and new challenges, requiring new transformation and development.


To share innovative practices in clinical trial management and technology and promote exchange and collaboration across the clinical trial ecosystem, at this turn of the year, the Linyanren platform is hosting the Linyanren 2022 Annual Conference and Clinical Trial Management and Technology Innovation Forum. Due to the pandemic, this forum will be held online, and all clinical research professionals are sincerely invited to attend!

"


EClinCloud CEO Dr. Qin Long has been invited to attend and will deliver an online presentation, looking forward to discussing current industry topics of interest with fellow experts.




Forum Agenda
Article image

   



Article image
Dr. Qin Long
CEO, EClinCloud


  • Over 16 years of experience in technology applications within the clinical research industry;

  • An innovative and inspiring leader, and a pioneer in promoting and implementing technology solutions such as eCOA, EDC, and CTMS in China's clinical trial research field;

  • Previously served as Asia-Pacific head for several international technology companies, leading rapid business growth in the region;

  • An entrepreneur driven by academia and science, deeply committed to shaping new models for future clinical trials.


 Forum Information 


Forum Theme:

Clinical Trial Management and Technology Innovation


Forum Organizer:

Linyanren Platform


Forum Time:

December 24, 2022, 09:00–17:00


Scan QR Code to Register:

This forum is open free of charge to the public and industry professionals. Please scan the QR code below to enter the livestream room and watch.


Article image

 *For more forum information, please follow the "Linyanren Home" (临研人之家) WeChat official account.




About EClinCloud

EClinCloud is a technology company dedicated to clinical R&D. It provides an integrated, interoperable all-in-one clinical trial cloud platform (including technology products such as CTMS, eTMF, EDC, RTSM, eCOA, and eConsent, as well as solutions including scale management, linguistic validation, rater training, and data quality analysis) and clinical trial endpoint assessment technologies across therapeutic areas (including oncology, central nervous system, ophthalmology, and more). By combining cutting-edge technology with life data to build a globally leading, patient-centric SaaS cloud platform for clinical evidence support, EClinCloud helps domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the launch of drugs and medical devices, and benefit countless patients.




Article image


Read original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.